Neuroscience Journal Publications
This page includes links to Lilly sponsored clinical trials that have been published in peer reviewed journals over the last 3 years. Each section is sorted by product and may be expanded by each phase. The list of publications below is limited to products that have been approved for use and may contain information about doses, delivery devices, uses, formulations and populations different from product labeling. Clinical decisions should be based on the full safety and efficacy information contained in the product's Full Prescribing Information in the provided link below.
If you have questions about a Lilly study not listed below or would like to request an electronic copy of one of the journal publications on this page, please Contact Lilly services.
Amyvid
Radiation dosimetry and pharmacokinetics of florbetapir (18F) in Japanese subjects
Published Date: May 28, 2019
Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
Published Date: July 11, 2018
Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET
Published Date: April 9, 2019
Efficacy and Limitations of rCBF-SPECT in the Diagnosis of Alzheimer's Disease With Amyloid-PET
Published Date: April 9, 2019
No Publications.
Cymbalta
No Publications.
No Publications.
Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data
Published Date: April 23, 2019
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back Pain
Published Date: March 11, 2019
Emgality
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies
Published Date: September 17, 2018
Response to 'Do different treatment strategies of galcanezumab have similar effect on migraine?'
Published Date: February 12, 2020
CGRP blockade by galcanezumab was not associated with reductions in signs and symptoms of knee osteoarthritis in a randomized clinical trial
Published Date: September 19, 2018
Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine
Published Date: April 27, 2020
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review
Published Date: April 21, 2020
Response to 'Do different treatment strategies of galcanezumab have similar effect on migraine?'
Published Date: February 12, 2020
Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Published Date: November 11, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
Published Date: July 11, 2019
Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability
Published Date: July 3, 2019
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure
Published Date: June 3, 2019
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Published Date: April 3, 2019
Galcanezumab in chronic migraine: The randomized, double-blind, placebo-controlled REGAIN study
Published Date: November 16, 2018
A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine
Published Date: November 9, 2018
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies
Published Date: September 17, 2018
Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial
Published Date: May 29, 2018
No Publications.
Reyvow
Effects of Lasmiditan on Cardiovascular Parameters and Pharmacokinetics in Healthy Subjects Receiving Oral Doses of Propranolol
Published Date: January 16, 2020
Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study
Published Date: November 20, 2019
Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study
Published Date: February 24, 2020
Lasmiditan for the acute treatment of migraine: Subgroup analyses by prior response to triptans
Published Date: November 19, 2019
Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN
Published Date: July 3, 2019
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Published Date: May 28, 2019
Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study
Published Date: December 11, 2018
No Publications.
Strattera
No Publications.
No Publications.
No Publications.
No Publications.